Mark Eisner - 01 Dec 2022 Form 4 Insider Report for FIBROGEN INC (FGEN)

Role
Chief Medical Officer
Signature
/s/ Cecelia Monoarfa-Taime, Attorney-in-Fact
Issuer symbol
FGEN
Transactions as of
01 Dec 2022
Transactions value $
-$16,303
Form type
4
Filing time
02 Dec 2022, 16:41:35 UTC
Previous filing
04 Oct 2022
Next filing
23 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FGEN Common Stock Tax liability -$16.3K -1.08K -0.76% $15.04* 141K 01 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.